Eurofins Scient (OTCMKTS:ERFSF – Get Free Report)’s stock price gapped down prior to trading on Friday . The stock had previously closed at $81.96, but opened at $77.7380. Eurofins Scient shares last traded at $77.7380, with a volume of 37 shares trading hands.
Analyst Upgrades and Downgrades
ERFSF has been the subject of a number of research reports. Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Eurofins Scient in a report on Wednesday, October 29th. Citigroup restated a “neutral” rating on shares of Eurofins Scient in a research report on Monday, February 2nd. Finally, BNP Paribas Exane raised shares of Eurofins Scient to an “outperform” rating in a research note on Monday, January 5th. One analyst has rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold”.
Check Out Our Latest Analysis on ERFSF
Eurofins Scient Stock Down 2.4%
About Eurofins Scient
Eurofins Scientific is a global provider of bioanalytical testing and laboratory services, offering a wide array of testing solutions to pharmaceutical, food, environmental, agriscience and consumer products industries. Its core services include pharmaceutical quality control, environmental testing for water and air quality, food safety analysis, agrochemical trials and clinical diagnostic support. The company operates specialized laboratories equipped with advanced analytical technologies such as chromatography, mass spectrometry and molecular biology to ensure compliance with regulatory standards and to support research and development efforts across multiple sectors.
Founded in 1987 by Gilles Martin and headquartered in Luxembourg, Eurofins has grown through a combination of organic expansion and strategic acquisitions.
See Also
- Five stocks we like better than Eurofins Scient
- Have $500? Invest in Elon’s AI Masterplan
- 3 Signs You May Want to Switch Financial Advisors
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Fewer Than 1% of Americans Own This Undervalued Asset — Should You?
Receive News & Ratings for Eurofins Scient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eurofins Scient and related companies with MarketBeat.com's FREE daily email newsletter.
